Trial Profile
A Phase 1/Phase 2, Randomized, Double-Blind, Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Effect on Opioid Analgesia of TD-1211 Administered Orally to Healthy Volunteers and to Assess the Safety, Pharmacokinetics, and Effect on Bowel Movements in Subjects With Opioid-Induced Constipation
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 31 Jan 2019
Price :
$35
*
At a glance
- Drugs Axelopran (Primary)
- Indications Constipation
- Focus Adverse reactions
- Sponsors Theravance
- 25 Jun 2014 New trial record